{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T06:00:19Z","timestamp":1787032819740,"version":"build-2736575974"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,6,15]]},"DOI":"10.7759\/cureus.15663","type":"journal-article","created":{"date-parts":[[2021,6,15]],"date-time":"2021-06-15T10:59:25Z","timestamp":1623754765000},"source":"Crossref","is-referenced-by-count":5,"title":["Past, Present, and Future of Gonadotropin Use in Controlled Ovarian Stimulation During Assisted Reproductive Techniques"],"prefix":"10.7759","author":[{"given":"Anastasia","family":"Prodromidou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elli","family":"Anagnostou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Depy","family":"Mavrogianni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanouela","family":"Liokari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangelia","family":"Dimitroulia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petros","family":"Drakakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Loutradis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1017\/S0967199417000168","article-title":"Influence of gonadotropins on ovarian follicle growth and development in vivo and in vitro","volume":"25","author":"Filatov M","year":"2017","unstructured":"Filatov M, Khramova Y, Parshina E, Bagaeva T, Semenova M. Influence of gonadotropins on ovarian follicle growth and development in vivo and in vitro. Zygote. 2017, 25:235-43. 10.1017\/S0967199417000168","journal-title":"Zygote"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18051059","article-title":"Human chorionic gonadotropin: the pregnancy hormone and more","volume":"18","author":"Theofanakis C","year":"2017","unstructured":"Theofanakis C, Drakakis P, Besharat A, Loutradis D. Human chorionic gonadotropin: the pregnancy hormone and more. Int J Mol Sci. 2017, 18:10.3390\/ijms18051059","journal-title":"Int J Mol Sci"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2013.12.009","article-title":"Luteinizing hormone and human chorionic gonadotropin: origins of difference","volume":"383","author":"Choi J","year":"2014","unstructured":"Choi J, Smitz J. Luteinizing hormone and human chorionic gonadotropin: origins of difference. Mol Cell Endocrinol. 2014, 383:203-13. 10.1016\/j.mce.2013.12.009","journal-title":"Mol Cell Endocrinol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2019.00429","article-title":"The development of gonadotropins for clinical use in the treatment of infertility","volume":"10","author":"Lunenfeld B","year":"2019","unstructured":"Lunenfeld B, Bilger W, Longobardi S, Alam V, D'Hooghe T, Sunkara SK. The development of gonadotropins for clinical use in the treatment of infertility. Front Endocrinol (Lausanne). 2019, 10:429. 10.3389\/fendo.2019.00429","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/bs.pmbts.2016.08.002","article-title":"Clinical applications of gonadotropins in the female: assisted reproduction and beyond","volume":"143","author":"Casarini L","year":"2016","unstructured":"Casarini L, Brigante G, Simoni M, Santi D. Clinical applications of gonadotropins in the female: assisted reproduction and beyond. Prog Mol Biol Transl Sci. 2016, 143:85-119. 10.1016\/bs.pmbts.2016.08.002","journal-title":"Prog Mol Biol Transl Sci"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005354.pub2","article-title":"Recombinant versus urinary gonadotrophin for ovarian stimulation in assisted reproductive technology cycles","author":"van Wely M","year":"2011","unstructured":"van Wely M, Kwan I, Burt AL, Thomas J, Vail A, Van der Veen F, Al-Inany HG. Recombinant versus urinary gonadotrophin for ovarian stimulation in assisted reproductive technology cycles. Cochrane Database Syst Rev. 2011, CD005354. 10.1002\/14651858.CD005354.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.21037\/atm.2019.04.16","article-title":"Clinical outcomes following long GnRHa ovarian stimulation with highly purified human menopausal gonadotropin plus rFSH or rFSH in patients undergoing <i>in vitro<\/i> fertilization-embryo transfer: a multi-center randomized controlled trial","volume":"7","author":"Shu L","year":"2019","unstructured":"Shu L, Xu Q, Meng Q, et al.. Clinical outcomes following long GnRHa ovarian stimulation with highly purified human menopausal gonadotropin plus rFSH or rFSH in patients undergoing &lt;i&gt;in vitro&lt;\/i&gt; fertilization-embryo transfer: a multi-center randomized controlled trial. Ann Transl Med. 2019, 7:146. 10.21037\/atm.2019.04.16","journal-title":"Ann Transl Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.rbmo.2019.08.010","article-title":"HMG versus recombinant FSH plus recombinant LH in ovarian stimulation for IVF: does the source of LH preparation matter?","volume":"39","author":"Orvieto R","year":"2019","unstructured":"Orvieto R. HMG versus recombinant FSH plus recombinant LH in ovarian stimulation for IVF: does the source of LH preparation matter?. Reprod Biomed Online. 2019, 39:1001-6. 10.1016\/j.rbmo.2019.08.010","journal-title":"Reprod Biomed Online"},{"key":"ref9","doi-asserted-by":"crossref","DOI":"10.12891\/ceog3216.2016","article-title":"Addition of low-dose hCG to rFSH during ovarian stimulation for IVF\/ICSI: is it beneficial?","volume":"43","author":"Partsinevelos GA","year":"2016","unstructured":"Partsinevelos GA, Antonakopoulos N, Kallianidis K, Drakakis P, Anagnostou E, Bletsa R, Loutradis D. Addition of low-dose hCG to rFSH during ovarian stimulation for IVF\/ICSI: is it beneficial?. Clin Exp Obstet Gynecol. 2016, 43:818-25.","journal-title":"Clin Exp Obstet Gynecol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7827-7-91","article-title":"\"hCG priming\" effect in controlled ovarian stimulation through a long protocol","volume":"7","author":"Beretsos P","year":"2009","unstructured":"Beretsos P, Partsinevelos GA, Arabatzi E, et al.. \"hCG priming\" effect in controlled ovarian stimulation through a long protocol. Reprod Biol Endocrinol. 2009, 7:91. 10.1186\/1477-7827-7-91","journal-title":"Reprod Biol Endocrinol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2004.12.021","article-title":"Small doses of LH activity are needed early in ovarian stimulation for better quality oocytes in IVF-ET","volume":"121","author":"Drakakis P","year":"2005","unstructured":"Drakakis P, Loutradis D, Kallianidis K, et al.. Small doses of LH activity are needed early in ovarian stimulation for better quality oocytes in IVF-ET. Eur J Obstet Gynecol Reprod Biol. 2005, 121:77-80. 10.1016\/j.ejogrb.2004.12.021","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-003-0544-3","article-title":"Results of controlled ovarian stimulation for ART in poor responders according to the short protocol using different gonadotrophins combinations","volume":"270","author":"Loutradis D","year":"2004","unstructured":"Loutradis D, Elsheikh A, Kallianidis K, Drakakis P, Stefanidis K, Milingos S, Michalas S. Results of controlled ovarian stimulation for ART in poor responders according to the short protocol using different gonadotrophins combinations. Arch Gynecol Obstet. 2004, 270:223-6. 10.1007\/s00404-003-0544-3","journal-title":"Arch Gynecol Obstet"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jogoh.2019.02.012","article-title":"The impact of HCG in IVF treatment: does it depend on age or on protocol?","volume":"48","author":"Theofanakis C","year":"2019","unstructured":"Theofanakis C, Athanasiou V, Liokari E, et al.. The impact of HCG in IVF treatment: does it depend on age or on protocol?. J Gynecol Obstet Hum Reprod. 2019, 48:341-5. 10.1016\/j.jogoh.2019.02.012","journal-title":"J Gynecol Obstet Hum Reprod"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7827-7-110","article-title":"Early hCG addition to rFSH for ovarian stimulation in IVF provides better results and the cDNA copies of the hCG receptor may be an indicator of successful stimulation","volume":"7","author":"Drakakis P","year":"2009","unstructured":"Drakakis P, Loutradis D, Beloukas A, et al.. Early hCG addition to rFSH for ovarian stimulation in IVF provides better results and the cDNA copies of the hCG receptor may be an indicator of successful stimulation. Reprod Biol Endocrinol. 2009, 7:110. 10.1186\/1477-7827-7-110","journal-title":"Reprod Biol Endocrinol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2017.00114","article-title":"Efficacy of follicle-stimulating hormone (FSH) alone, FSH\u2009+\u2009luteinizing hormone, human menopausal gonadotropin or FSH\u2009+\u2009human chorionic gonadotropin on assisted reproductive technology outcomes in the \"personalized\" medicine era: a meta-analysis","volume":"8","author":"Santi D","year":"2017","unstructured":"Santi D, Casarini L, Alviggi C, Simoni M. Efficacy of follicle-stimulating hormone (FSH) alone, FSH\u2009+\u2009luteinizing hormone, human menopausal gonadotropin or FSH\u2009+\u2009human chorionic gonadotropin on assisted reproductive technology outcomes in the \"personalized\" medicine era: a meta-analysis. Front Endocrinol (Lausanne). 2017, 8:114. 10.3389\/fendo.2017.00114","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2012.02.049","article-title":"Efficacy and safety of human chorionic gonadotropin for follicular phase stimulation in assisted reproduction: a systematic review and meta-analysis","volume":"97","author":"Checa MA","year":"2012","unstructured":"Checa MA, Espin\u00f3s JJ, Requena A. Efficacy and safety of human chorionic gonadotropin for follicular phase stimulation in assisted reproduction: a systematic review and meta-analysis. Fertil Steril. 2012, 97:1343-50.e1-3. 10.1016\/j.fertnstert.2012.02.049","journal-title":"Fertil Steril"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7827-10-55","article-title":"Addition of low dose hCG to rFSh benefits older women during ovarian stimulation for IVF","volume":"10","author":"Gomaa H","year":"2012","unstructured":"Gomaa H, Casper RF, Esfandiari N, Chang P, Bentov Y. Addition of low dose hCG to rFSh benefits older women during ovarian stimulation for IVF. Reprod Biol Endocrinol. 2012, 10:55. 10.1186\/1477-7827-10-55","journal-title":"Reprod Biol Endocrinol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2012.01.130","article-title":"The use of recombinant luteinizing hormone in patients undergoing assisted reproductive techniques with advanced reproductive age: a systematic review and meta-analysis","volume":"97","author":"Hill MJ","year":"2012","unstructured":"Hill MJ, Levens ED, Levy G, Ryan ME, Csokmay JM, DeCherney AH, Whitcomb BW. The use of recombinant luteinizing hormone in patients undergoing assisted reproductive techniques with advanced reproductive age: a systematic review and meta-analysis. Fertil Steril. 2012, 97:1108-14.e1. 10.1016\/j.fertnstert.2012.01.130","journal-title":"Fertil Steril"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7827-12-17","article-title":"Recombinant human follicle-stimulating hormone (r-hFSH) plus recombinant luteinizing hormone versus r-hFSH alone for ovarian stimulation during assisted reproductive technology: systematic review and meta-analysis","volume":"12","author":"Lehert P","year":"2014","unstructured":"Lehert P, Kolibianakis EM, Venetis CA, et al.. Recombinant human follicle-stimulating hormone (r-hFSH) plus recombinant luteinizing hormone versus r-hFSH alone for ovarian stimulation during assisted reproductive technology: systematic review and meta-analysis. Reprod Biol Endocrinol. 2014, 12:17. 10.1186\/1477-7827-12-17","journal-title":"Reprod Biol Endocrinol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.rbmo.2017.05.001","article-title":"Bio-equivalent doses of recombinant HCG and recombinant LH during ovarian stimulation result in similar oestradiol output: a randomized controlled study","volume":"35","author":"Alsbjerg B","year":"2017","unstructured":"Alsbjerg B, Elbaek HO, Laursen RJ, Povlsen BB, Haahr T, Yding Andersen C, Humaidan P. Bio-equivalent doses of recombinant HCG and recombinant LH during ovarian stimulation result in similar oestradiol output: a randomized controlled study. Reprod Biomed Online. 2017, 35:232-8. 10.1016\/j.rbmo.2017.05.001","journal-title":"Reprod Biomed Online"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deh625","article-title":"Recombinant human LH supplementation versus recombinant human FSH (rFSH) step-up protocol during controlled ovarian stimulation in normogonadotrophic women with initial inadequate ovarian response to rFSH. A multicentre, prospective, randomized controlled trial","volume":"20","author":"De Placido G","year":"2005","unstructured":"De Placido G, Alviggi C, Perino A, et al.. Recombinant human LH supplementation versus recombinant human FSH (rFSH) step-up protocol during controlled ovarian stimulation in normogonadotrophic women with initial inadequate ovarian response to rFSH. A multicentre, prospective, randomized controlled trial. Hum Reprod. 2005, 20:390-6. 10.1093\/humrep\/deh625","journal-title":"Hum Reprod"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005070.pub3","article-title":"Recombinant luteinizing hormone (rLH) and recombinant follicle stimulating hormone (rFSH) for ovarian stimulation in IVF\/ICSI cycles","volume":"5","author":"Mochtar MH","year":"2017","unstructured":"Mochtar MH, Danhof NA, Ayeleke RO, Van der Veen F, van Wely M. Recombinant luteinizing hormone (rLH) and recombinant follicle stimulating hormone (rFSH) for ovarian stimulation in IVF\/ICSI cycles. Cochrane Database Syst Rev. 2017, 5:CD005070. 10.1002\/14651858.CD005070.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dev038","article-title":"Recombinant follicle-stimulating hormone and recombinant luteinizing hormone versus recombinant follicle-stimulating hormone alone during GnRH antagonist ovarian stimulation in patients aged \u226535 years: a randomized controlled trial","volume":"30","author":"Vuong TN","year":"2015","unstructured":"Vuong TN, Phung HT, Ho MT. Recombinant follicle-stimulating hormone and recombinant luteinizing hormone versus recombinant follicle-stimulating hormone alone during GnRH antagonist ovarian stimulation in patients aged \u226535 years: a randomized controlled trial. Hum Reprod. 2015, 30:1188-95. 10.1093\/humrep\/dev038","journal-title":"Hum Reprod"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/det266","article-title":"Recombinant LH supplementation to a standard GnRH antagonist protocol in women of 35 years or older undergoing IVF\/ICSI: a randomized controlled multicentre study","volume":"28","author":"K\u00f6nig TE","year":"2013","unstructured":"K\u00f6nig TE, van der Houwen LE, Overbeek A, et al.. Recombinant LH supplementation to a standard GnRH antagonist protocol in women of 35 years or older undergoing IVF\/ICSI: a randomized controlled multicentre study. Hum Reprod. 2013, 28:2804-12. 10.1093\/humrep\/det266","journal-title":"Hum Reprod"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-014-0204-4","article-title":"Human recombinant follicle stimulating hormone (rFSH) compared to urinary human menopausal gonadotropin (HMG) for ovarian stimulation in assisted reproduction: a literature review and cost evaluation","volume":"38","author":"Levi Setti PE","year":"2015","unstructured":"Levi Setti PE, Alviggi C, Colombo GL, et al.. Human recombinant follicle stimulating hormone (rFSH) compared to urinary human menopausal gonadotropin (HMG) for ovarian stimulation in assisted reproduction: a literature review and cost evaluation. J Endocrinol Invest. 2015, 38:497-503. 10.1007\/s40618-014-0204-4","journal-title":"J Endocrinol Invest"},{"key":"ref26","article-title":"Human menopausal gonadotropin versus recombinant FSH in polycystic ovary syndrome patients undergoing in vitro fertilization","volume":"6","author":"Figen Turkcapar A","year":"2013","unstructured":"Figen Turkcapar A, Seckin B, Onalan G, Ozdener T, Batioglu S. Human menopausal gonadotropin versus recombinant FSH in polycystic ovary syndrome patients undergoing in vitro fertilization. Int J Fertil Steril. 2013, 6:238-43.","journal-title":"Int J Fertil Steril"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2007.10.022","article-title":"GnRH agonist versus GnRH antagonist in ovarian stimulation: the role of endometrial receptivity","volume":"90","author":"Orvieto R","year":"2008","unstructured":"Orvieto R, Meltzer S, Rabinson J, Zohav E, Anteby EY, Nahum R. GnRH agonist versus GnRH antagonist in ovarian stimulation: the role of endometrial receptivity. Fertil Steril. 2008, 90:1294-6. 10.1016\/j.fertnstert.2007.10.022","journal-title":"Fertil Steril"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1080\/09513590.2018.1528221","article-title":"GnRH antagonist versus follicular-phase single-dose GnRH agonist protocol in patients of normal ovarian responses during controlled ovarian stimulation","volume":"35","author":"Geng Y","year":"2019","unstructured":"Geng Y, Xun Y, Hu S, Lai Q, Jin L. GnRH antagonist versus follicular-phase single-dose GnRH agonist protocol in patients of normal ovarian responses during controlled ovarian stimulation. Gynecol Endocrinol. 2019, 35:309-13. 10.1080\/09513590.2018.1528221","journal-title":"Gynecol Endocrinol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jogoh.2017.09.007","article-title":"Pregnancy outcomes after controlled ovarian hyperstimulation in women with endometriosis-associated infertility: GnRH-agonist versus GnRH-antagonist","volume":"46","author":"Kolanska K","year":"2017","unstructured":"Kolanska K, Cohen J, Bendifallah S, et al.. Pregnancy outcomes after controlled ovarian hyperstimulation in women with endometriosis-associated infertility: GnRH-agonist versus GnRH-antagonist. J Gynecol Obstet Hum Reprod. 2017, 46:681-6. 10.1016\/j.jogoh.2017.09.007","journal-title":"J Gynecol Obstet Hum Reprod"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2005.02.033","article-title":"Novel concepts of human chorionic gonadotropin: reproductive system interactions and potential in the management of infertility","volume":"84","author":"Filicori M","year":"2005","unstructured":"Filicori M, Fazleabas AT, Huhtaniemi I, Licht P, Rao ChV, Tesarik J, Zygmunt M. Novel concepts of human chorionic gonadotropin: reproductive system interactions and potential in the management of infertility. Fertil Steril. 2005, 84:275-84. 10.1016\/j.fertnstert.2005.02.033","journal-title":"Fertil Steril"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1002\/mrd.20883","article-title":"Regulation of granulosa and theca cell transcriptomes during ovarian antral follicle development","volume":"75","author":"Skinner MK","year":"2008","unstructured":"Skinner MK, Schmidt M, Savenkova MI, Sadler-Riggleman I, Nilsson EE. Regulation of granulosa and theca cell transcriptomes during ovarian antral follicle development. Mol Reprod Dev. 2008, 75:1457-72. 10.1002\/mrd.20883","journal-title":"Mol Reprod Dev"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-1528","article-title":"Intrafollicular endocrine milieu after addition of hCG to recombinant FSH during controlled ovarian stimulation for in vitro fertilization","volume":"99","author":"Thuesen LL","year":"2014","unstructured":"Thuesen LL, Andersen AN, Loft A, Smitz J. Intrafollicular endocrine milieu after addition of hCG to recombinant FSH during controlled ovarian stimulation for in vitro fertilization. J Clin Endocrinol Metab. 2014, 99:517-26. 10.1210\/jc.2013-1528","journal-title":"J Clin Endocrinol Metab"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/j.repbio.2016.01.004","article-title":"Effect of recombinant-LH and hCG in the absence of FSH on in vitro maturation (IVM) fertilization and early embryonic development of mouse germinal vesicle (GV)-stage oocytes","volume":"16","author":"Dinopoulou V","year":"2016","unstructured":"Dinopoulou V, Drakakis P, Kefala S, et al.. Effect of recombinant-LH and hCG in the absence of FSH on in vitro maturation (IVM) fertilization and early embryonic development of mouse germinal vesicle (GV)-stage oocytes. Reprod Biol. 2016, 16:138-46. 10.1016\/j.repbio.2016.01.004","journal-title":"Reprod Biol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.2174\/138920112799361891","article-title":"ESR1, ESR2 and FSH receptor gene polymorphisms in combination: a useful genetic tool for the prediction of poor responders","volume":"13","author":"Anagnostou E","year":"2012","unstructured":"Anagnostou E, Mavrogianni D, Theofanakis C, et al.. ESR1, ESR2 and FSH receptor gene polymorphisms in combination: a useful genetic tool for the prediction of poor responders. Curr Pharm Biotechnol. 2012, 13:426-34. 10.2174\/138920112799361891","journal-title":"Curr Pharm Biotechnol"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1007\/s10815-012-9729-7","article-title":"LH receptor gene expression in cumulus cells in women entering an ART program","volume":"29","author":"Papamentzelopoulou M","year":"2012","unstructured":"Papamentzelopoulou M, Mavrogianni D, Partsinevelos GA, et al.. LH receptor gene expression in cumulus cells in women entering an ART program. J Assist Reprod Genet. 2012, 29:409-16. 10.1007\/s10815-012-9729-7","journal-title":"J Assist Reprod Genet"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/57432-past-present-and-future-of-gonadotropin-use-in-controlled-ovarian-stimulation-during-assisted-reproductive-techniques","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T14:35:12Z","timestamp":1707489312000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/57432-past-present-and-future-of-gonadotropin-use-in-controlled-ovarian-stimulation-during-assisted-reproductive-techniques"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,15]]},"references-count":35,"URL":"https:\/\/doi.org\/10.7759\/cureus.15663","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6,15]]}}}